SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-24-038733
Filing Date
2024-05-02
Accepted
2024-05-01 21:54:01
Documents
12

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 ea0205072-s1a2_virpax.htm S-1/A 498988
2 FORM OF SERIES A-1 COMMON WARRANT ea020507201ex4-4_virpax.htm EX-4.4 89788
3 FORM OF SERIES A-2 COMMON WARRANT ea020507201ex4-5_virpax.htm EX-4.5 89980
4 FORM OF PRE-FUNDED WARRANT ea020507201ex4-6_virpax.htm EX-4.6 94235
5 OPINION OF BLANK ROME LLP ea020507201ex5-1_virpax.htm EX-5.1 15457
6 FORM OF SECURITIES PURCHASE AGREEMENT TO BE ENTERED INTO IN THIS OFFERING ea020507201ex10-40_virpax.htm EX-10.40 257037
7 CONSENT OF EISNERAMPER LLP ea020507201ex23-1_virpax.htm EX-23.1 2945
8 FILING FEE TABLE ea020507201ex-fee_virpax.htm EX-FILING FEES 22159
9 GRAPHIC image_001.jpg GRAPHIC 4282
10 GRAPHIC image_002.jpg GRAPHIC 129724
11 GRAPHIC image_003.jpg GRAPHIC 110735
12 GRAPHIC ex5-1_001.jpg GRAPHIC 5636
  Complete submission text file 0001213900-24-038733.txt   1417087
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-278796 | Film No.: 24904895
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)